Drug Delivery
Ananya Shivakumar (she/her/hers)
Undergraduate Researcher at University of Pittsburgh
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Alireza Mohammadzadeh
Mentor and PhD student
University of Pittsburgh, United States
Steven Little, PhD
William Kepler Whiteford Endowed Professor of Chemical and Petroleum Engineering, Bioengineering
University of Pittsburgh, United States
Liposome Preparation Liposomes were created using a microfluidic hydrodynamic flow focusing chip then purified using a dialysis bag (12-14 kDa MWCO). The lipid phase consisted of soybean lecithin, cholesterol, and CHEMS which were mixed in a 3.4:1:10.6 molar ratio in 20 mL of IPA and filtered twice using a 0.22 um filter. The aqueous phase consisted of 0.116 mg/mL of Rhodamine B Dye which was also filtered twice using a 0.22 um filter. The dye acts as a drug excipient in order to more easily record the cargo release. The total flow rate (TFR) was 300 μL/min and the flow rate ratio (FRR) was 1:2 (lipid:aqueous) such that liposomes consisting of an aqueous, cargo containing, core were produced in the outlet channel. Refer to Figure 1. The resulting liposomal solution was then purified in a dialysis bag for at least three days in phosphate buffered saline (PBS) to remove any excess lipid or dye molecules.
1. Immordino, M. L., Dosio, F., & Cattel, L. (2006). Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International journal of nanomedicine, 1(3), 297.
2. Revathy, T., Jayasri, M. A., & Suthindhiran, K. (2016). Antimicrobial magnetosomes for topical antimicrobial therapy. In Nanobiomaterials in Antimicrobial Therapy (pp. 67-101). William Andrew Publishing.